Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-11-22

Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled Study: CroFab® vs Placebo for Copperhead Snake Envenomation [Phase 4]

View source ↗

Summary

Phase 4 randomized, double-blind, placebo-controlled study evaluating CroFab for copperhead snake envenomation; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CroFab (Crotalidae Immune Fab (Ovine))

Snippet

Sponsor: BTG International Inc. | Conditions: Snake Bites | Phase 4 | Status: COMPLETED | Results posted: 2017-11-22